Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 110 peer-reviewed journal articles Updated
Medical Genetics · Neurodevelopmental Delay-Intellectual Disability-Skeletal Defects Syndromes

Neurodevelopmental Delay-Intellectual Disability-Skeletal Defects Syndromes: A Patient Guide

At a Glance

Neurodevelopmental delay-intellectual disability-skeletal defects syndrome is usually a descriptive label for several rare genetic disorders. Identifying the specific gene can clarify the diagnosis and guide individualized therapies, specialist monitoring, and family planning discussions.

Receiving a diagnosis of neurodevelopmental delay-intellectual disability-skeletal defects syndrome is often the first step in moving from a period of uncertainty toward a personalized care plan for your child or loved one. It is important to understand that this name is often a descriptive diagnosis—an umbrella term used to group children and adults who share similar challenges while doctors work to identify the specific genetic “instruction” that is different [1][2]. This descriptive label encompasses several distinct, ultra-rare genetic disorders, such as ZTTK syndrome (caused by the SON gene), Rauch-Steindl syndrome (the NSD2 gene), and IDDOF (the MTSS2 gene) [3][4][5].

What this label does and does not tell you: A descriptive label identifies shared symptoms, but the exact gene, variant classification, and clinician interpretation determine the specific care plan. The guide is not a substitute for individualized medical advice based on the exact diagnosis.

Although these conditions are caused by different genes, they often present with overlapping features because many of the genes involved help the body build the brain and the skeleton during early development [6][7]. Common core symptoms can include global developmental delay (missing milestones like walking or talking), intellectual disability (challenges with learning and everyday skills), hypotonia (low muscle tone), and skeletal defects like short stature or differences in bone age [3][5][4]. Because these syndromes are so rare, finding the specific gene through tests chosen by a geneticist—such as chromosomal microarray, Whole Exome Sequencing, or targeted testing—is critical; it allows your medical team to move beyond general symptoms and tailor monitoring and treatments to the individual’s exact biological needs, though it is important to know that testing has limitations and sometimes a cause is not found [8][9].

While there is currently no single cure for these genetic differences, proactive management significantly improves a person’s quality of life and long-term outcomes. The “standard of care” focuses on individualized support, including physical, occupational, and speech therapies, which help the brain and body find new ways to learn and grow [10][11]. By working with a multidisciplinary team of specialists—including geneticists, neurologists, and orthopedists—you can ensure that your loved one has the support they need to reach their own personal best [12][13]. Their path may be different from others, but with a confirmed diagnosis and a dedicated team, you can shift your focus from searching for answers to supporting their unique journey [14].

In this guide

6 chapters

01

Validation & Orientation: Understanding a Descriptive Diagnosis

Learn what neurodevelopmental delay-intellectual disability-skeletal defects syndrome means, why it may be a descriptive diagnosis, and how care is planned.

02

Finding the Specific Genetic Cause

Learn how genetic testing can find the cause of neurodevelopmental delay, intellectual disability, and skeletal defects, including test choices and inheritance.

03

Symptoms, Skeletal Defects, and Warning Signs

Learn the symptoms and emergency warning signs of neurodevelopmental delay-intellectual disability-skeletal defects syndromes, including hypotonia and seizures.

04

Understanding Your Genetic Report

Learn how to read a genetic report for neurodevelopmental delay, intellectual disability, and skeletal defects, including variants, inheritance, and reanalysis.

05

Building Your Care Team and Treatment Strategy

Learn how ZTTK, RAUST, and MTSS2-related IDDOF are managed with coordinated specialists, therapies, seizure care, skeletal monitoring, and family support.

06

Monitoring, Communication, and Quality of Life

Learn how ZTTK and related neurodevelopmental syndromes are monitored, while AAC supports communication and families plan adult care and caregiver support.

Common questions in this guide

What does a neurodevelopmental delay-intellectual disability-skeletal defects diagnosis mean?
It is usually a descriptive umbrella label for several rare genetic conditions that share developmental, learning, muscle-tone, and skeletal features. The exact gene and genetic change determine the more specific diagnosis and help guide care.
What genetic tests can identify the cause of these syndromes?
Geneticists may use chromosomal microarray, whole exome sequencing, or targeted testing, depending on the person’s features and prior results. Testing can identify a cause, but it has limits and sometimes does not find one.
What symptoms are common in these genetic syndromes?
Common features include delayed milestones such as walking or talking, intellectual disability, low muscle tone, short stature, and differences in bone age. The combination and severity vary, so one person may not have every feature.
How are neurodevelopmental delay syndromes treated?
There is no single cure for these genetic differences, so care is individualized. Physical, occupational, and speech therapies, along with coordinated care from specialists, can support movement, communication, learning, and daily skills.
Which specialists and baseline tests might my child need?
Care may involve a geneticist, neurologist, orthopedist, and the child’s local pediatric team. Depending on the exact gene and symptoms, clinicians may recommend baseline evaluations such as brain imaging or bone-age X-rays.
Can this diagnosis affect future pregnancies?
Recurrence risk depends on the exact gene, genetic change, and how the condition is inherited. A genetics professional can review the report and give a family-specific estimate before or during a future pregnancy.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Neurodevelopmental delay-intellectual disability-skeletal defects syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the exact gene and variant listed on my child's report, and is there a more specific syndrome name we should use?
  2. 2.Which of the symptoms—such as muscle tone or spinal alignment—require immediate specialist evaluation?
  3. 3.How can we ensure that our local pediatric team and our school district are coordinated with the genetics specialists?
  4. 4.Based on this genetic result, what are the chances of this condition recurring in future pregnancies?
  5. 5.What specific screenings (like brain imaging or bone age X-rays) do you recommend as a baseline for my child based on their exact gene?

References

References (14)
  1. 1

    Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases.

    Domaradzki J, Walkowiak D

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):78-84 doi:10.1016/j.ejpn.2023.12.003.

    PMID: 38071849
  2. 2

    MTSS2 -Related Disorder: Refining the Phenotype in Four New Cases and Literature Review.

    Dominicis A, Sparascio FP, Stregapede F, et al.

    American journal of medical genetics. Part A 2025; (197(6)):e64010 doi:10.1002/ajmg.a.64010.

    PMID: 39890443
  3. 3

    ZTTK syndrome: Clinical and molecular findings of 15 cases and a review of the literature.

    Kushary ST, Revah-Politi A, Barua S, et al.

    American journal of medical genetics. Part A 2021; (185(12)):3740-3753 doi:10.1002/ajmg.a.62445.

    PMID: 34331327
  4. 4

    Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.

    Zanoni P, Steindl K, Sengupta D, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(8)):1474-1483 doi:10.1038/s41436-021-01158-1.

    PMID: 33941880
  5. 5

    MTSS2-related neurodevelopmental disorder: Further delineation of the phenotype.

    Corona-Rivera JR, Zenteno JC, Ordoñez-Labastida V, et al.

    European journal of medical genetics 2023; (66(10)):104826 doi:10.1016/j.ejmg.2023.104826.

    PMID: 37657631
  6. 6

    Knockdown of Son, a mouse homologue of the ZTTK syndrome gene, causes neuronal migration defects and dendritic spine abnormalities.

    Ueda M, Matsuki T, Fukada M, et al.

    Molecular brain 2020; (13(1)):80 doi:10.1186/s13041-020-00622-4.

    PMID: 32448361
  7. 7

    The constitutional gain-of-function variant p.Glu1099Lys in NSD2 is associated with a novel syndrome.

    Popp B, Brugger M, Poschmann S, et al.

    Clinical genetics 2023; (103(2)):226-230 doi:10.1111/cge.14241.

    PMID: 36189577
  8. 8

    Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

    Manickam K, McClain MR, Demmer LA, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(11)):2029-2037 doi:10.1038/s41436-021-01242-6.

    PMID: 34211152
  9. 9

    Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.

    Srivastava S, Love-Nichols JA, Dies KA, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(11)):2413-2421 doi:10.1038/s41436-019-0554-6.

    PMID: 31182824
  10. 10

    Effectiveness of Early Intervention Programs for Young Children with Global Developmental Delay: A Systematic Review :.

    Almuhanna SM, Alshehri OA, B Alsaadoon BM, et al.

    Galen medical journal 2025; (14()):e3906 doi:10.31661/gmj.vi.3906.

    PMID: 42038902
  11. 11

    A multicenter clinical study on parent-implemented early intervention for children with global developmental delay.

    Dong P, Xu Q, Zhang Y, et al.

    Frontiers in pediatrics 2023; (11()):1052665 doi:10.3389/fped.2023.1052665.

    PMID: 36873631
  12. 12

    Consensus recommendations on organization of care for individuals with Phelan-McDermid syndrome.

    van Eeghen AM, Stemkens D, Fernández-Fructuoso JR, et al.

    European journal of medical genetics 2023; (66(7)):104747 doi:10.1016/j.ejmg.2023.104747.

    PMID: 37003574
  13. 13

    Development of models of care coordination for rare conditions: a qualitative study.

    Walton H, Simpson A, Ramsay AIG, et al.

    Orphanet journal of rare diseases 2022; (17(1)):49 doi:10.1186/s13023-022-02190-3.

    PMID: 35164822
  14. 14

    Children with a rare congenital genetic disorder: a systematic review of parent experiences.

    von der Lippe C, Neteland I, Feragen KB

    Orphanet journal of rare diseases 2022; (17(1)):375 doi:10.1186/s13023-022-02525-0.

    PMID: 36253830

This overview of neurodevelopmental delay-intellectual disability-skeletal defects syndromes is for education and does not replace medical advice. A genetics team should interpret the exact gene result and tailor care for your child or loved one.